{"name":"MB Venture Capital Fund","permalink":"mb-venture-capital-fund","crunchbase_url":"http://www.crunchbase.com/financial-organization/mb-venture-capital-fund","homepage_url":"http://www.mbventures.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"901-322-0330 ","description":"Venture Capital Firm","email_address":"","number_of_employees":null,"founded_year":2001,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Apr 22 12:31:06 UTC 2010","updated_at":"Wed Sep 22 14:59:16 UTC 2010","overview":"<p>MB Venture Partners is a venture capital firm specializing in investments in all stages of development. The firm does not invest in healthcare services, healthcare IT, and AgBio opportunities. It prefers to invest in seed or early stage financing but select later- stage financing are also considered. The firm typically invests in life sciences sector including biotechnology and medical device companies with a focus on: product solutions for musculoskeletal diseases, products to alleviate human suffering, and molecular therapeutics. It seeks to invest in opportunities across the United States for musculoskeletal related investments and Southeast and Midwest regions for investments in biotechnology, medical devices companies, and non-musculoskeletal investments. MB Venture Partners was founded in 2001 and is based in Memphis, Tennessee.</p>","image":{"available_sizes":[[[150,30],"assets/images/resized/0010/2652/102652v1-max-150x150.jpg"],[[238,48],"assets/images/resized/0010/2652/102652v1-max-250x250.jpg"],[[238,48],"assets/images/resized/0010/2652/102652v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"HQ","address1":"17 West Pontotoc ","address2":"Suite 200","zip_code":"38103","city":"Memphis","state_code":"TN","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.onyvax.com/html/press_releases/1/2006_05_08_Fundraising.html","source_description":"Onyvax Raises Â£8 Million to Advance Development of Prostate Cancer Vaccine","raised_amount":8000000,"raised_currency_code":"GBP","funded_year":2006,"funded_month":5,"funded_day":8,"company":{"name":"Onyvax","permalink":"onyvax","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4586/84586v1-max-150x150.jpg"],[[210,66],"assets/images/resized/0008/4586/84586v1-max-250x250.jpg"],[[210,66],"assets/images/resized/0008/4586/84586v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/anulex-technologies-inc-series-e-183m/","source_description":"Anulex Technologies, Inc.: Series E $18.3M","raised_amount":18300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":7,"company":{"name":"Anulex","permalink":"anulex","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9175/49175v1-max-150x150.png"],[[184,50],"assets/images/resized/0004/9175/49175v1-max-250x250.png"],[[184,50],"assets/images/resized/0004/9175/49175v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/onbiovc-post-1000-axiomed-spine-corp-series-d-15m/","source_description":"**OnBioVC Post 1,000** AxioMed Spine Corp.: Series D $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":25,"company":{"name":"AxioMed Spine","permalink":"axiomed-spine","image":{"available_sizes":[[[150,43],"assets/images/resized/0010/7451/107451v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0010/7451/107451v1-max-250x250.jpg"],[[326,95],"assets/images/resized/0010/7451/107451v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Biomed Fund III","funded_year":2011,"funded_month":11,"funded_day":16,"raised_amount":22000000,"raised_currency_code":"USD","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020111116e7bgpw043&r=Rss&s=DJFVW","source_description":"MB Venture Partners Gathers $22M For New Biomed Fund "}],"video_embeds":[],"external_links":[]}